Intravenous immunoglobulin infusion reaction
Adverse reactions during IVIG/immunoglobulin therapy · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Reactions to immunoglobulin therapy are usually rate-related (headache, flushing, myalgia, fever, chest tightness) and settle with slowing the infusion, but anaphylaxis can occur, particularly in IgA-deficient patients with anti-IgA antibodies. Serious delayed complications include aseptic meningitis, thrombosis, haemolysis and acute kidney injury.
Red flags
- Wheeze, hypotension or angioedema (anaphylaxis)
- Severe headache with neck stiffness (aseptic meningitis)
- Chest pain, dyspnoea or focal deficit (thrombosis)
- Dark urine / falling haemoglobin (haemolysis)
- Oliguria or rising creatinine (acute kidney injury)
Assessment
Differential diagnosis
- Rate-related infusion reaction (most common)
- True anaphylaxis (anti-IgA antibodies in IgA deficiency)
- Aseptic meningitis (delayed)
- Haemolytic reaction from isoagglutinins
- Volume overload / thrombosis
Investigations
- Observations and continuous monitoring during infusion
- FBC and haptoglobin/LDH if haemolysis suspected
- Renal function (acute kidney injury with sucrose-containing products)
- IgA level and anti-IgA antibodies if recurrent/anaphylactic reactions
- Tryptase if anaphylaxis suspected
Management
- For mild rate-related symptoms, slow or pause the infusion and observe
- Give paracetamol and antihistamine for headache, flushing and fever
- Resume at a slower rate once symptoms settle
- For anaphylaxis, stop the infusion and treat with IM adrenaline, oxygen and fluids
- Ensure adequate hydration to reduce thrombosis and renal risk
- Investigate IgA deficiency/anti-IgA antibodies after a severe reaction and use IgA-depleted product
- Pre-medicate and reduce infusion rate for subsequent cycles if prior reactions
- Consider switching to subcutaneous immunoglobulin for recurrent systemic reactions
Drugs & doses
Paracetamol — 1 g orally/IV as premedication and symptom relief
Chlorphenamine — 10 mg IV/IM for flushing/urticaria
Hydrocortisone — 100-200 mg IV for moderate-severe reactions
Adrenaline IM — 500 mcg (0.5 mL 1:1000) for anaphylaxis
0.9% sodium chloride — IV hydration to reduce thrombotic/renal risk
Disposition
Continue monitored infusion after mild reactions; admit anaphylaxis or serious complications and review product choice/route before the next cycle.
Complications & pitfalls
- Anaphylaxis in IgA-deficient recipients
- Aseptic meningitis
- Thromboembolism (arterial and venous)
- Haemolytic anaemia from isoagglutinins
- Acute kidney injury and volume overload
Exam pearls
- Most reactions are rate-related and respond to slowing the infusion
- Suspect anti-IgA antibodies in anaphylaxis — check IgA and use IgA-depleted product
- Keep patients well hydrated to mitigate thrombotic and renal risk
- Subcutaneous immunoglobulin has fewer systemic reactions for recurrent reactors
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.